News for Sino Biopharmaceutical Limited (SMZ1.MU)

Published at

Feb 23, 2021 11:56 PM

by marketscreener.com

mixed

mixed

Sino Biopharmaceutical : VONLUNTARY ANNOUNCEMENT - ENTERING INTO AN OVERSEAS LICENSING COOPERATION AGREEMENT WITH GRAVITON

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its... | February 23, 2021

SMZ1.MU SMZ1.F SMZ1.BE SBMFF 1177.HK HKXCF HK2C.MU HK2C.F 0388.HK

Read more →
Published at

Feb 23, 2021 11:31 PM

by marketscreener.com

mixed

mixed

Akeso : VOLUNTARY ANNOUNCEMENT - INTERIM ANALYSIS OF THE PHASE III CLINICAL TRIAL OF PENPULIMAB MONOCLONAL ANTIBODY (PD-1) IN COMBINATION WITH CHEMOTHERAPY FOR FIRST-LINE SQUAMOUS NON-SMALL CELL LUNG

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its... | February 23, 2021

SMZ1.MU SMZ1.F SMZ1.BE SBMFF 9926.HK 4RY.F 1177.HK HKXCF HK2C.MU HK2C.F 0388.HK

Read more →